Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: A meta-analysis

Annals of Nuclear Medicine

Volumn 29, Issue 5, 2015, Pages 409-419

  Pak, Kyoungjune ^a   Park, Sohyun ^b   Cheon, Gi Jeong ^b   Kang, Keon Wook ^b   Kim, In Joo ^a   Lee, Dong Soo ^b,c   Kim, E Edmund ^c,d   Chung, June Key ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinoma non small cell lung; Neoplasm staging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUBERCULOSIS; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER ASSISTED TOMOGRAPHY; DEVICES; LYMPH NODE; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84943348533     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-015-0958-6     Document Type: Article

References (58)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. 2014. CA Cancer J Clin. 2014; 64(1): 9-29.
2. Health NIo. Surveillance, Epidemiology, and End Results Program: National Cancer Institue; [cited 2014].
3. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, et al. Non-small cell lung cancer. J Natl Compr Cancer Netw JNCCN. 2010; 8(7): 740-801.
4. Kim YN, Yi CA, Lee KS, Kwon OJ, Lee HY, Kim BT, et al. A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer. Eur Radiol. 2012; 22(7): 1537-46.
5. Prenzel KL, Monig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest. 2003; 123(2): 463-7.
6. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology. 1999; 213(2): 530-6.
7. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac surg. 2004; 78(3): 1017-23 (discussion 1027-23).
8. Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009; 151(4): 221-8 W-48.
9. Lv YL, Yuan DM, Wang K, Miao XH, Qian Q, Wei SZ, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011; 6(8): 1350-8.
10. Liao CY, Chen JH, Liang JA, Yeh JJ, Kao CH. Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in nonsmall cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol. 2012; 81(11): 3518-23.
11. Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, et al. Preoperative mediastinal and hilar nodal staging with diffusionweighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res. 2012; 178(1): 304-14.
12. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8): 529-36.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 557-60.
14. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001; 20(19): 2865-84.
15. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005; 58(10): 982-90.
16. Kraemer HC. Evaluating medical tests: objective and quantitative guidelines. Newbury Park, CA: SAGE; 1992.
17. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9): 882-93.
18. An YS, Sun JS, Park KJ, Hwang SC, Park KJ, Sheen SS, et al. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. Lung. 2008; 186(5): 327-36.
19. Bille A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur Journal Cardio-thorac Surg Off J Eur Assoc Cardio-thorac Surg. 2009; 36(3): 440-5.
20. Booth K, Hanna GG, McGonigle N, McManus KG, McGuigan J, O'Sullivan J, et al. The mediastinal staging accuracy of 18FFluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery. Ulst Med J. 2013; 82(2): 75-81.
21. Ceylan N, Dogan S, Kocacelebi K, Savas R, Cakan A, Cagrici U. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer. Diagn Interv Radiol. 2012; 18(5): 435-40.
22. Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in nonsmall cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011; 6(8): 1367-72.
23. Fischer BM, Mortensen J, Hansen H, Vilmann P, Larsen SS, Loft A, et al. Multimodality approach to mediastinal staging in nonsmall cell lung cancer. Faults and benefits of PET-CT: a randomised trial. Thorax. 2011; 66(4): 294-300.
24. Hwangbo B, Kim SK, Lee HS, Lee HS, Kim MS, Lee JM, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest. 2009; 135(5): 1280-7.
25. Kim DW, Kim WH, Kim CG. Dual-time-point FDG PET/CT: is it useful for lymph node staging in patients with non-small-cell lung cancer? Nucl Med Mol Imaging. 2012; 46(3): 196-200.
26. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2007; 109(6): 1068-77.
27. Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, et al. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Acad Radiol. 2012; 19(6): 685-92.
28. Lee AY, Choi SJ, Jung KP, Park JS, Lee SM, Bae SK. Characteristics of metastatic mediastinal lymph nodes of non-small cell lung cancer on preoperative F-18 FDG PET/CT. Nucl Med Mol Imaging. 2014; 48(1): 41-6.
29. Lee BE, von Haag D, Lown T, Lau D, Calhoun R, Follette D. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007; 133(3): 746-52.
30. Lee HJ, Kim YT, Kang WJ, Lee HJ, Kang CH, Kim JH. Integrated positron-emission tomography for nodal staging in lung cancer. Asian Cardiovasc Thorac Ann. 2009; 17(6): 622-6.
31. Lee SM, Park CM, Paeng JC, Im HJ, Goo JM, Lee HJ, et al. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol. 2012; 22(7): 1556-63.
32. Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, et al. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage nonsmall cell lung cancer: a multicenter study. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2012; 102(2): 246-50.
33. Lin WY, Hsu WH, Lin KH, Wang SJ. Role of preoperative PETCT in assessing mediastinal and hilar lymph node status in early stage lung cancer. J Chin Med Assoc JCMA. 2012; 75(5): 203-8.
34. Liu BJ, Dong JC, Xu CQ, Zuo CT, Le JJ, Guan YH, et al. Accuracy of 18F-FDG PET/CT for lymph node staging in nonsmall-cell lung cancers. Chin Med J. 2009; 122(15): 1749-54.
35. Mona A, El-Hariri GKG, Ali M. Refat. Integrated PET/CT in the preoperative staging of lung cancer: a prospective comparison of CT, PET and integrated PET/CT. Egypt J Radiol Nucl Med. 2012; 43(4): 613-21.
36. Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008; 135(4): 816-22.
37. Ohno Y, Koyama H, Yoshikawa T, Nishio M, Aoyama N, Onishi Y, et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology. 2011; 261(2): 605-15.
38. Ose N, Sawabata N, Minami M, Inoue M, Shintani Y, Kadota Y, et al. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Eur J Cardio-thorac Surg Off J Eur Assoc Cardiothorac Surg. 2012; 42(1): 89-92.
39. Plathow C, Aschoff P, Lichy MP, Eschmann S, Hehr T, Brink I, et al. Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer-initial results. Invest Radiol. 2008; 43(5): 290-7.
40. Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Interact CardioVasc Thorac Surg. 2010; 10(2): 200-3.
41. Toba H, Kondo K, Otsuka H, Takizawa H, Kenzaki K, Sakiyama S, et al. Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer. J Med Invest JMI. 2010; 57(3-4): 305-13.
42. Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax. 2007; 62(8): 696-701.
43. Ventura E, Islam T, Gee MS, Mahmood U, Braschi M, Harisinghani MG. Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT. Clin Imaging. 2010; 34(1): 20-8.
44. Xu N, Wang M, Zhu Z, Zhang Y, Jiao Y, Fang W. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer. Chin Med J. 2014; 127(4): 607-13.
45. World Health Organization WHO. TB data: World health organization. http://www. who. int/tb/country/data/download/en/. Accessed 1 Jan 2015.
46. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007; 48(6): 932-45.
47. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003; 56(11): 1129-35.
48. Ha S, Choi H, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS. Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: a Preliminary Result. Nucl Med Mol Imaging. 2014; 48(4): 278-86.
49. Surti S. Update on Time-of-Flight PET Imaging. J Nucl Med. 2015; 56(1): 98-105.
50. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003; 139(11): 879-92.
51. Birim O, Kappetein AP, Stijnen T, Bogers AJ. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg. 2005; 79(1): 375-82.
52. Alongi F, Ragusa P, Montemaggi P, Bona CM. Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer. Tumori. 2006; 92(4): 327-33.
53. Lv YL, Yuan DM, Wang K, Miao XH, Qian Q, Wei SZ, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis. J Thorac Oncol. 2011; 6(8): 1350-8.
54. Liao CY, Chen JH, Liang JA, Yeh JJ, Kao CH. Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in nonsmall cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol. 2012; 81(11): 3518-23.
55. Wang J, Welch K, Wang L, Kong FMS. Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 nonsmall-cell lung cancer: a meta-analysis. Clin Lung Cancer. 2012; 13(2): 81-9.
56. Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, et al. Preoperative mediastinal and hilar nodal staging with diffusionweighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res. 2012; 178(1): 304-14.
57. Alongi F, Ragusa P, Montemaggi P, Bona CM. Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer. Tumori. 2006; 92(4): 327-33.
58. Wang J, Welch K, Wang L, Kong FM. Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis. Clin Lung Cancer. 2012; 13(2): 81-9.